BACKGROUND: Nephron hypertrophy and nephrosclerosis may be important determinants of CKD and mortality. However, studies of outcomes associated with these microstructural features have been limited to small tissue specimens from patients selected for either good kidney health or known kidney disease. METHODS: To determine whether microstructural features are predictive of progressive CKD and mortality outcomes, we studied patients who underwent a radical nephrectomy for a tumor. Large wedge sections of renal parenchyma distal to the tumor were stained and scanned into high-resolution images; we annotated the cortex and all glomeruli to calculate glomerular volume, cortex volume per glomerulus, and percentage of globally sclerotic glomeruli. Morphometric measurements also included percentages of artery luminal stenosis and interstitial fibrosis/tubular atrophy (IF/TA) of the cortex. At follow-up visits every 6-12 months, we determined which patients experienced progressive CKD (defined as dialysis, kidney transplantation, or a 40% decline from postnephrectomy eGFR). Cox models for these outcomes were adjusted for age, sex, body mass index, hypertension, diabetes, smoking, eGFR, and proteinuria. RESULTS: Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73 m2), 117 progressive CKD events, 183 noncancer deaths, and 116 cancer deaths occurred during a median follow-up of 6.4 years. Larger glomerular volume, larger cortex per glomerulus, and higher percentage of globally sclerotic glomeruli or IF/TA predicted progressive CKD. Higher percentage IF/TA also predicted noncancer mortality. Microstructural features did not predict cancer mortality or recurrence. CONCLUSIONS: After a radical nephrectomy, larger nephrons and nephrosclerosis predicted progressive CKD, and IF/TA predicted noncancer mortality. Morphometric analysis of renal parenchyma can predict noncancer clinical events in patients long after their radical nephrectomy.
BACKGROUND:Nephron hypertrophy and nephrosclerosis may be important determinants of CKD and mortality. However, studies of outcomes associated with these microstructural features have been limited to small tissue specimens from patients selected for either good kidney health or known kidney disease. METHODS: To determine whether microstructural features are predictive of progressive CKD and mortality outcomes, we studied patients who underwent a radical nephrectomy for a tumor. Large wedge sections of renal parenchyma distal to the tumor were stained and scanned into high-resolution images; we annotated the cortex and all glomeruli to calculate glomerular volume, cortex volume per glomerulus, and percentage of globally sclerotic glomeruli. Morphometric measurements also included percentages of artery luminal stenosis and interstitial fibrosis/tubular atrophy (IF/TA) of the cortex. At follow-up visits every 6-12 months, we determined which patients experienced progressive CKD (defined as dialysis, kidney transplantation, or a 40% decline from postnephrectomy eGFR). Cox models for these outcomes were adjusted for age, sex, body mass index, hypertension, diabetes, smoking, eGFR, and proteinuria. RESULTS: Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73 m2), 117 progressive CKD events, 183 noncancer deaths, and 116 cancer deaths occurred during a median follow-up of 6.4 years. Larger glomerular volume, larger cortex per glomerulus, and higher percentage of globally sclerotic glomeruli or IF/TA predicted progressive CKD. Higher percentage IF/TA also predicted noncancer mortality. Microstructural features did not predict cancermortality or recurrence. CONCLUSIONS: After a radical nephrectomy, larger nephrons and nephrosclerosis predicted progressive CKD, and IF/TA predicted noncancer mortality. Morphometric analysis of renal parenchyma can predict noncancer clinical events in patients long after their radical nephrectomy.
Authors: Musab S Hommos; Caihong Zeng; Zhihong Liu; Jonathan P Troost; Avi Z Rosenberg; Matthew Palmer; Walter K Kremers; Lynn D Cornell; Fernando C Fervenza; Laura Barisoni; Andrew D Rule Journal: Kidney Int Date: 2017-12-19 Impact factor: 10.612
Authors: Pegah Dejban; Elena M Wilson; Muthuvel Jayachandran; Loren P Herrera Hernandez; Zejfa Haskic; Linda E Wellik; Sutapa Sinha; Andrew D Rule; Aleksandar Denic; Kevin Koo; Aaron M Potretzke; John C Lieske Journal: Clin J Am Soc Nephrol Date: 2022-01-25 Impact factor: 8.237
Authors: Elise Marechal; Adrien Jaugey; Georges Tarris; Michel Paindavoine; Jean Seibel; Laurent Martin; Mathilde Funes de la Vega; Thomas Crepin; Didier Ducloux; Gilbert Zanetta; Sophie Felix; Pierre Henri Bonnot; Florian Bardet; Luc Cormier; Jean-Michel Rebibou; Mathieu Legendre Journal: Clin J Am Soc Nephrol Date: 2021-12-03 Impact factor: 8.237
Authors: Aleksandar Denic; Marija Bogojevic; Aidan F Mullan; Moldovan Sabov; Muhammad S Asghar; Sanjeev Sethi; Maxwell L Smith; Fernando C Fervenza; Richard J Glassock; Musab S Hommos; Andrew D Rule Journal: J Am Soc Nephrol Date: 2022-08-03 Impact factor: 14.978
Authors: Luisa Ricaurte Archila; Aleksandar Denic; Aidan F Mullan; Ramya Narasimhan; Marija Bogojevic; R Houston Thompson; Bradley C Leibovich; S Jeson Sangaralingham; Maxwell L Smith; Mariam P Alexander; Andrew D Rule Journal: J Am Soc Nephrol Date: 2021-06-18 Impact factor: 14.978
Authors: Nattawat Klomjit; Xiang-Yang Zhu; Alfonso Eirin; Aditya S Pawar; Sabena M Conley; Amrutesh S Puranik; Christopher M Ferguson; Seo Rin Kim; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman Journal: Nephrol Dial Transplant Date: 2022-09-22 Impact factor: 7.186
Authors: Abhijit S Naik; Su Q Wang; Mahboob Chowdhury; Jawad Aqeel; Christopher L O'Connor; Jocelyn E Wiggins; Markus Bitzer; Roger C Wiggins Journal: Sci Rep Date: 2021-10-01 Impact factor: 4.379
Authors: Inger T Enoksen; Dmitri Svistounov; Jon V Norvik; Vidar T N Stefansson; Marit D Solbu; Bjørn O Eriksen; Toralf Melsom Journal: Nephrol Dial Transplant Date: 2022-08-22 Impact factor: 7.186